期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
NRR instructions for authors --Guidelines for original articles
1
《Neural Regeneration Research》 SCIE CAS CSCD 2008年第1期13-13,共1页
The general rules for abstracts of original articles in NRR are as follows: ○ Should be concise and understandable independent of the main text. ○ Objectively summarize the content of primary documents; do not decla... The general rules for abstracts of original articles in NRR are as follows: ○ Should be concise and understandable independent of the main text. ○ Objectively summarize the content of primary documents; do not declare authors’ opinions. ○ The active voice is preferred over 展开更多
关键词 Guidelines for original articles NRR instructions for authors
下载PDF
Instructions for Original Articles (1)
2
《Neural Regeneration Research》 SCIE CAS CSCD 2006年第1期86-86,共1页
Title: The title should be brief, concise, peculiar and direct to the main subjects, with the avoidance of "investigate, study, analyze, observe and explore"; The Arabic numbers and definite article are not accepta... Title: The title should be brief, concise, peculiar and direct to the main subjects, with the avoidance of "investigate, study, analyze, observe and explore"; The Arabic numbers and definite article are not acceptable for beginning, The abbreviation (except the commonly used ones, such as CT). 展开更多
关键词 Instructions for original articles
下载PDF
ORIGINAL ARTICLES CALCIUM CHANNEL BLOCKERS IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION 被引量:4
3
作者 李定国 陆汉明 +3 位作者 李宣海 权启镇 李新民 陆玮 《Chinese Medical Journal》 SCIE CAS CSCD 1995年第11期5-10,共6页
Four calcium channel blockers, i.e. nifedipine, verapamil, cinnarizine and tetrandrine are currently available and used widely in treating cardiovascular diseases. To confirm the effects, if any, of calcium channel bl... Four calcium channel blockers, i.e. nifedipine, verapamil, cinnarizine and tetrandrine are currently available and used widely in treating cardiovascular diseases. To confirm the effects, if any, of calcium channel blockers on cirrhotic patients with portal hypertension, a study was performed on esophageal variceal pressure and rebleeding rate of esophageal varices after 2 years by using calcium channel blocker in 321 patients from some 23 hospitals. The results demonstrated that the calcium channel blockers could significantly reduce the esophageal variceal pressure and the portal blood flow in cirrhotic patients with portal hypertension. The proportion of patients with no recurrent gastrointestinal bleeding after 2 years medication of tetrandrine was 87.9% in tetrandrine group, significantly higher than those in the other 4 groups (P<0.05). It is suggested that tetrandrine should be more effective for cirrhotic patients with portal hypertension in preventing recurrent variceal bleeding. 展开更多
关键词 CCB original articles CALCIUM CHANNEL BLOCKERS IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION NIF SPV In IV THAN
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部